CROCS INC (CROX) Fundamental Analysis & Valuation

NASDAQ:CROX • US2270461096

Current stock price

107.35 USD
-3.84 (-3.45%)
At close:
107.35 USD
0 (0%)
After Hours:

This CROX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CROX Profitability Analysis

1.1 Basic Checks

  • In the past year CROX was profitable.
  • In the past year CROX had a positive cash flow from operations.
  • Of the past 5 years CROX 4 years were profitable.
  • CROX had a positive operating cash flow in each of the past 5 years.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B -1.5B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.94%, CROX is doing worse than 62.22% of the companies in the same industry.
  • CROX has a worse Return On Equity (-6.28%) than 64.44% of its industry peers.
  • The Return On Invested Capital of CROX (20.18%) is better than 93.33% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CROX is significantly above the industry average of 9.53%.
Industry RankSector Rank
ROA -1.94%
ROE -6.28%
ROIC 20.18%
ROA(3y)11.62%
ROA(5y)18.77%
ROE(3y)33.33%
ROE(5y)1062.57%
ROIC(3y)20.49%
ROIC(5y)25.32%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K 4K 5K

1.3 Margins

  • CROX has a better Operating Margin (21.97%) than 95.56% of its industry peers.
  • CROX's Operating Margin has improved in the last couple of years.
  • CROX's Gross Margin of 58.33% is fine compared to the rest of the industry. CROX outperforms 75.56% of its industry peers.
  • In the last couple of years the Gross Margin of CROX has grown nicely.
Industry RankSector Rank
OM 21.97%
PM (TTM) N/A
GM 58.33%
OM growth 3Y-3.7%
OM growth 5Y4.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.69%
GM growth 5Y1.52%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. CROX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CROX is creating value.
  • CROX has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CROX has less shares outstanding
  • The debt/assets ratio for CROX is higher compared to a year ago.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 4.01 indicates that CROX is not in any danger for bankruptcy at the moment.
  • CROX has a better Altman-Z score (4.01) than 73.33% of its industry peers.
  • The Debt to FCF ratio of CROX is 1.87, which is an excellent value as it means it would take CROX, only 1.87 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.87, CROX belongs to the top of the industry, outperforming 82.22% of the companies in the same industry.
  • CROX has a Debt/Equity ratio of 0.95. This is a neutral value indicating CROX is somewhat dependend on debt financing.
  • CROX's Debt to Equity ratio of 0.95 is on the low side compared to the rest of the industry. CROX is outperformed by 73.33% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for CROX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 1.87
Altman-Z 4.01
ROIC/WACC1.85
WACC10.89%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

2.3 Liquidity

  • CROX has a Current Ratio of 1.27. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
  • CROX has a Current ratio of 1.27. This is amonst the worse of the industry: CROX underperforms 86.67% of its industry peers.
  • CROX has a Quick Ratio of 1.27. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.74, CROX is doing worse than 86.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.74
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CROX Growth Analysis

3.1 Past

  • The earnings per share for CROX have decreased by -5.40% in the last year.
  • Measured over the past years, CROX shows a very strong growth in Earnings Per Share. The EPS has been growing by 30.96% on average per year.
  • Looking at the last year, CROX shows a decrease in Revenue. The Revenue has decreased by -1.50% in the last year.
  • Measured over the past years, CROX shows a very strong growth in Revenue. The Revenue has been growing by 23.86% on average per year.
EPS 1Y (TTM)-5.4%
EPS 3Y4.47%
EPS 5Y30.96%
EPS Q2Q%-9.13%
Revenue 1Y (TTM)-1.5%
Revenue growth 3Y4.36%
Revenue growth 5Y23.86%
Sales Q2Q%-3.25%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.01% on average over the next years.
  • CROX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.35% yearly.
EPS Next Y8.95%
EPS Next 2Y7.81%
EPS Next 3Y5.36%
EPS Next 5Y5.01%
Revenue Next Year1.03%
Revenue Next 2Y1.81%
Revenue Next 3Y1.07%
Revenue Next 5Y3.35%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

8

4. CROX Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.63, the valuation of CROX can be described as very reasonable.
  • CROX's Price/Earnings ratio is rather cheap when compared to the industry. CROX is cheaper than 93.33% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.66, CROX is valued rather cheaply.
  • A Price/Forward Earnings ratio of 7.92 indicates a rather cheap valuation of CROX.
  • Based on the Price/Forward Earnings ratio, CROX is valued cheaper than 97.78% of the companies in the same industry.
  • CROX is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.00, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.63
Fwd PE 7.92
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 88.89% of the companies in the same industry are more expensive than CROX, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CROX is valued cheaply inside the industry as 95.56% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.18
EV/EBITDA 6.71
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CROX may justify a higher PE ratio.
PEG (NY)0.96
PEG (5Y)0.28
EPS Next 2Y7.81%
EPS Next 3Y5.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CROX Dividend Analysis

5.1 Amount

  • CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CROX Fundamentals: All Metrics, Ratios and Statistics

CROCS INC

NASDAQ:CROX (4/21/2026, 8:00:01 PM)

After market: 107.35 0 (0%)

107.35

-3.84 (-3.45%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)02-12
Earnings (Next)04-30
Inst Owners99.98%
Inst Owner Change0.01%
Ins Owners3.49%
Ins Owner Change9.11%
Market Cap5.39B
Revenue(TTM)4.04B
Net Income(TTM)-81.20M
Analysts72.17
Price Target107.34 (-0.01%)
Short Float %9.24%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.66%
Min EPS beat(2)18.22%
Max EPS beat(2)21.1%
EPS beat(4)4
Avg EPS beat(4)15.32%
Min EPS beat(4)3.5%
Max EPS beat(4)21.1%
EPS beat(8)8
Avg EPS beat(8)15.96%
EPS beat(12)12
Avg EPS beat(12)14.53%
EPS beat(16)16
Avg EPS beat(16)15.58%
Revenue beat(2)2
Avg Revenue beat(2)1.95%
Min Revenue beat(2)1.48%
Max Revenue beat(2)2.42%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)2.42%
Revenue beat(8)5
Avg Revenue beat(8)0.91%
Revenue beat(12)7
Avg Revenue beat(12)0.59%
Revenue beat(16)10
Avg Revenue beat(16)0.81%
PT rev (1m)2.46%
PT rev (3m)15.42%
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)9.93%
EPS NY rev (1m)-0.12%
EPS NY rev (3m)10.76%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)0.22%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)1.53%
Valuation
Industry RankSector Rank
PE 8.63
Fwd PE 7.92
P/S 1.33
P/FCF 8.18
P/OCF 7.59
P/B 4.17
P/tB N/A
EV/EBITDA 6.71
EPS(TTM)12.44
EY11.59%
EPS(NY)13.55
Fwd EY12.63%
FCF(TTM)13.12
FCFY12.23%
OCF(TTM)14.14
OCFY13.18%
SpS80.44
BVpS25.75
TBVpS-8.68
PEG (NY)0.96
PEG (5Y)0.28
Graham Number84.892 (-20.92%)
Profitability
Industry RankSector Rank
ROA -1.94%
ROE -6.28%
ROCE 25.55%
ROIC 20.18%
ROICexc 20.97%
ROICexgc 43.42%
OM 21.97%
PM (TTM) N/A
GM 58.33%
FCFM 16.31%
ROA(3y)11.62%
ROA(5y)18.77%
ROE(3y)33.33%
ROE(5y)1062.57%
ROIC(3y)20.49%
ROIC(5y)25.32%
ROICexc(3y)21.34%
ROICexc(5y)28.15%
ROICexgc(3y)55.47%
ROICexgc(5y)57.23%
ROCE(3y)25.94%
ROCE(5y)32.05%
ROICexgc growth 3Y-10.15%
ROICexgc growth 5Y7.53%
ROICexc growth 3Y3.65%
ROICexc growth 5Y-5.95%
OM growth 3Y-3.7%
OM growth 5Y4.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.69%
GM growth 5Y1.52%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 1.87
Debt/EBITDA 1.27
Cap/Depr 64.62%
Cap/Sales 1.27%
Interest Coverage 11.43
Cash Conversion 73.47%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 0.74
Altman-Z 4.01
F-Score5
WACC10.89%
ROIC/WACC1.85
Cap/Depr(3y)125.61%
Cap/Depr(5y)1207.8%
Cap/Sales(3y)1.96%
Cap/Sales(5y)13.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.4%
EPS 3Y4.47%
EPS 5Y30.96%
EPS Q2Q%-9.13%
EPS Next Y8.95%
EPS Next 2Y7.81%
EPS Next 3Y5.36%
EPS Next 5Y5.01%
Revenue 1Y (TTM)-1.5%
Revenue growth 3Y4.36%
Revenue growth 5Y23.86%
Sales Q2Q%-3.25%
Revenue Next Year1.03%
Revenue Next 2Y1.81%
Revenue Next 3Y1.07%
Revenue Next 5Y3.35%
EBIT growth 1Y-15.14%
EBIT growth 3Y0.5%
EBIT growth 5Y28.92%
EBIT Next Year10.95%
EBIT Next 3Y2.56%
EBIT Next 5Y8.54%
FCF growth 1Y-28.59%
FCF growth 3YN/A
FCF growth 5Y24%
OCF growth 1Y-28.42%
OCF growth 3Y5.61%
OCF growth 5Y21.63%

CROCS INC / CROX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CROCS INC (CROX) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CROX.


What is the valuation status of CROCS INC (CROX) stock?

ChartMill assigns a valuation rating of 8 / 10 to CROCS INC (CROX). This can be considered as Undervalued.


How profitable is CROCS INC (CROX) stock?

CROCS INC (CROX) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CROX stock?

The Price/Earnings (PE) ratio for CROCS INC (CROX) is 8.63 and the Price/Book (PB) ratio is 4.17.


Can you provide the financial health for CROX stock?

The financial health rating of CROCS INC (CROX) is 6 / 10.